Table 1 |
|
|
Patient characteristics. |
|
|
Sex |
Number (%) |
|
|
|
|
Male |
8 (36%) |
|
|
|
|
Female |
14 (64%) |
|
|
|
|
Age, years |
|
|
|
|
|
Median (range) |
67 (42-91) |
|
|
|
|
Initial treatment |
|
|
|
|
|
Surgery alone |
8 (36%) |
|
|
|
|
Surgery + Post-operative Chemo-Radiation |
13 (59%) |
|
|
|
|
Radiation |
1 (5%) |
|
|
|
|
Prior radiation dose (Gy) |
|
|
|
|
|
Total (daily) dose range |
40-65 (1.5-2) |
|
|
|
|
Histology |
|
|
|
|
|
Squamous cell carcinoma |
21 (95.5%) |
|
|
|
|
M1 case |
1 (4.5%) |
|
|
|
|
Regions of recurrence or metastases |
|
|
|
|
|
Tongue |
7 (31.8%) |
|
|
|
|
Mandible |
5 (22.7%) |
|
|
|
|
Maxilla |
3 (13.6%) |
|
|
|
|
Maxillary sinus |
3 (13.6%) |
|
|
|
|
Soft palate |
2 (9.1%) |
|
|
|
|
Limited with lymph node |
1 (4.5%) |
|
|
|
|
Temporal muscle |
1 (4.5%) |
|
|
|
|
Clinical Stage |
|
|
|
|
|
rT0N1M0 |
1 (4.5%) |
|
|
|
|
rT0N0M1 |
1 (4.5%) |
|
|
|
|
rT2N0M0 |
3 (13.6%) |
|
|
|
|
rT3N0M0 |
5 (22.7%) |
|
|
|
|
rT3N1M0 |
2 (9.1%) |
|
|
|
|
rT3N2M0 |
1 (4.5%) |
|
|
|
|
rT4N0M0 |
5 (22.7%) |
|
|
|
|
rT4N1M0 |
2 (9.1%) |
|
|
|
|
rT4N2M0 |
2 (9.1%) |
|
|
|
|
Kawaguchi et al. Radiation Oncology 2010 5:51 doi:10.1186/1748-717X-5-51 |
|
